site stats

Syrs earnings report

WebAug 9, 2024 · Syros Pharmaceuticals, Inc. , which belongs to the Zacks Medical - Biomedical and Genetics industry, posted revenues of $6.28 million for the quarter ended June 2024, surpassing the Zacks Consensus... WebSyros Pharmaceuticals, Inc. (SYRS) Reports Q4 Loss, Lags Revenue Estimates Syros Pharmaceuticals, Inc. (SYRS) delivered earnings and revenue surprises of -0.79% and 123.02%, respectively, for the quarter ended December 2024.

Syros Pharmaceuticals, Inc. (SYRS) Reports Q3 Loss, Misses …

WebNov 14, 2024 · Syros Pharmaceuticals, Inc. (SYRS) came out with a quarterly loss of $2.41 per share versus the Zacks Consensus Estimate of a loss of $3.91. This compares to loss … WebMar 15, 2024 · Syros Pharmaceuticals, Inc. (SYRS) came out with a quarterly loss of $0.42 per share versus the Zacks Consensus Estimate of a loss of $0.44. This compares to loss of $0.61 per share a year ago. get all keys in dictionary python https://ricardonahuat.com

SYRS Stock Price Forecast. Should You Buy SYRS? - StockInvest.us

WebSYRS Syros Pharmaceuticals Inc. Stock Price & News - WSJ. DJIA 33485.29 0.01% . S&P 500 4105.02 0.36% . U.S. 10 Yr 0/32 Yield 3.405% . 0.13%. Web1 day ago · Syros Pharmaceuticals (SYRS) (Real Time Quote from BATS) $2.73 USD +0.11 (4.20%) Updated Apr 13, 2024 01:37 PM ET Add to portfolio Zacks Rank: 3-Hold 3 Style Scores: F Value F Growth D... christmas in paris crossword

Syros Pharmaceuticals, Inc. (SYRS) Reports Q4 Loss, Lags Revenue Est…

Category:SYRS Syros Pharmaceuticals Inc. Stock Price & News - WSJ

Tags:Syrs earnings report

Syrs earnings report

Syros Pharmaceuticals, Inc. (SYRS) Reports Q3 Loss, Misses …

WebRepresents the company's profit divided by the outstanding shares of its common stock. -0.17. 95.53%. EBITDA. Earnings before interest, taxes, depreciation, and amortization, is a measure of a ... WebSyros Pharmaceuticals (SYRS) Earnings Date & Reports 641 Followers Portfolio Earnings Data Report Date May 10, 2024 Not Confirmed Period Ending 2024 (Q1) Consensus EPS …

Syrs earnings report

Did you know?

WebMar 2, 2024 · Syros Pharmaceuticals, Inc. (SYRS) delivered earnings and revenue surprises of -0.79% and 123.02%, respectively, for the quarter ended December 2024. Web1 day ago · Price To Cash Flow is a widely used stock evaluation measure. Find the latest Price To Cash Flow for Syros Pharmaceuticals (SYRS)

WebDec 31, 2024 · Syros Pharmaceuticals ( SYRS) is scheduled to report earnings on May 15, 2024. The last reported earnings were for reported on March 2, 2024 for Q4. Q What were the latest earnings per... WebMar 31, 2024 · Current Quarter Estimates for SYRS. In the past 30 days, one estimate has gone higher for Syros Pharmaceuticals while no estimates have gone lower in the same time period. The trend has been pretty favorable too, with estimates increasing from a loss of 70 cents a share 30 days ago, to a loss of 61 cents today, a move of 13%.

WebBased on 5 Wall Street analysts offering 12 month price targets for Syros Pharmaceuticals in the last 3 months. The average price target is $24.00 with a high forecast of $60.00 and a low forecast of $13.00. The average price target represents a 858.08% change from the last price of $2.51. Highest Price Target $60.00. Average Price Target $24.00. WebNov 14, 2024 · Syros Pharmaceuticals, Inc., which belongs to the Zacks Medical - Biomedical and Genetics industry, posted revenues of $3.89 million for the quarter ended September 2024, missing the Zacks...

WebMar 15, 2024 · Syros Pharmaceuticals, Inc. (SYRS) delivered earnings and revenue surprises of 4.55% and 38.09%, respectively, for the quarter ended December 2024.

Web26 rows · Apr 8, 2024 · Syros Pharmaceuticals last posted its quarterly earnings results on March 2nd, 2024. The ... get all keys from object javascriptWebSyros Pharmaceuticals Inc. analyst ratings, historical stock prices, earnings estimates & actuals. SYRS updated stock price target summary. getallkeys localstorageWebApr 6, 2024 · Syros Pharmaceuticals reports Q4 EPS (17c), consensus ($1.35) Reports Q4 revenue ($754,000), consensus $3.72M. "In 2024, we advanced our efforts to develop new … christmas in paris castWebEarnings Summary For their last quarter, Syros Pharmaceuticals (SYRS) reported earnings of -$1.28 per share, missing the Zacks Consensus Estimate of -$1.27 per share. This … christmas in peachtree bluffWebMar 22, 2024 · Syros Pharmaceuticals, Inc. (SYRS) latest earnings report: revenue, EPS, surprise, history, news and analysis. Syros Pharmaceuticals, Inc. (SYRS) Earnings Report … christmas in paradise reviewWebSYRS Stock Price - Syros Pharmaceuticals, Inc. engages in the development of gene control therapies for cancer and diseases. Its product candidates include SY-1425, SY-2101, and … christmas in paris anita hughesWebMar 2, 2024 · Annual Reports; IRS Tax Form 8937; Stock Data. Quote; Charts; Historical Data; SEC Filings. All SEC Filings; Annual Filings; Quarterly Reports; Proxy; Section 16 Filings; Governance. Board of Directors; Board Committees; Governance Documents; Investor & … Syros to Report Fourth Quarter and Full Year 2024 Financial Results on Thursday, … Upcoming Events . There are no upcoming events scheduled at this time. Sign up … Do you want to load external content supplied by QMod Stock Tools? Yes We respect your privacy. We do not sell, rent, or loan any information to any third … Current report filing: 3: 03/02/23: S-8: Initial registration statement for securities to … © 2024 Syros Pharmaceuticals, Inc. All Rights Reserved. Privacy Policy Terms of … CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($) $ in Thousands. 12 … 2024 Annual Report. 2024 Annual Report. 2024 Annual Report Gerald brings more than 20 years of senior leadership and legal experience in the … get all keys from dictionary python